GLOBAL RENAL BIOMARKER MARKET RESEARCH AND FORECAST 2018-2023
Biotechnology Pharmaceuticals
DEFINITION
Kidney diseases or renal diseases is one of the major causes of deaths across the globe. The incidence of the renal diseases, particularly in geriatric population is rising rapidly owing to better life expectancy due to improvements in medical systems. Diabetes and high blood pressure are the leading cause of renal disease. A biomarker is an indicator of a specific biological state, relevant to the risk for, the presence of, or the stage of any disease. Biomarkers are clinically used for various purpose such as screening, diagnosing, or monitoring the activity of any diseases.
MARKET MOTIVATORS
Rising prevalence of various kidney related diseases Sparking innovation to improve the lives of people with kidney disease High population pool of diabetes and blood pressure- leading cause of renal disease Kidney injury biomarkers: value in drug development Awareness programmes for acute kidney injury(AKI)
MARKET RESTRAINTS
Lack of regulatory & reimbursement systems Limited market capabilities in underdeveloped markets
MARKET OPPORTUNITIES
Growing trend towards personalized medicine Rising demand from emerging economies
REGIONAL ANALYSIS
North America
Europe
APAC
ROW
MARKET SEGMENTATION
By type Diagnostic biomarkers Prognostic biomarkers Predictive biomarkers Pharmacodynamic biomarkers
MARKET SEGMENTATION
By diagnostic technique Elisa Colorimetric assay Liquid chromatography-mass spectrometry Particle-enhanced turbidimetric immunoassay
MARKET SEGMENTATION
By end users Hospitals Diagnostic labs Research centres
COMPANY PROFILE
Abbott laboratories Astellas pharma inc. Astute medical, inc. Bayer ag Beckman coulter inc.
To be continued……
FOR MORE DETAILS PLEASE VISIT OUR WEBSITE CONTACT US Orion Market Research Pvt. Ltd. (OMR Global) 116, Shagun Arcade, Vijay Nagar Square, Indore, Madhya Pradesh India- 452010 Global +1 646-755-7667 Asia +91 917-982-8694 info@omrglobal.com https://www.omrglobal.com
11